Patents by Inventor Michael Palladino

Michael Palladino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150047621
    Abstract: In a certain aspect, some embodiment provides apparatus and methods to facilitate the launching or throwing of streamer rolls, consisting of various paper, plastic and/or other materials, including in particular rolled paper or other material. Various embodiments provide such an apparatus that is safe and easy to use, durable, and/or economical to manufacture.
    Type: Application
    Filed: August 13, 2013
    Publication date: February 19, 2015
    Inventor: Michael Palladino
  • Patent number: 8618292
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: December 31, 2013
    Assignee: Beyondspring Pharmaceuticals, Inc.
    Inventors: Michael Palladino, George Kenneth Lloyd, Yoshio Hayashi
  • Patent number: 8394816
    Abstract: Disclosed are methods of treating Waldenstrom's Macroglobulinemia comprising administering to the animal, a therapeutically effective amount of a heterocyclic compound of Formula I.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: March 12, 2013
    Inventors: Irene Ghobrial, Aldo Roccaro, Dharminder Chauhan, Kenneth Anderson, Michael Palladino
  • Publication number: 20120329834
    Abstract: The present invention relates to the use of compounds of general formula (I): (I) for the preparation of medicaments that act against mitochondrial pathologies involving a deficiency in ATP production via the oxidative phosphorylation pathway, such as mitochondrial diseases.
    Type: Application
    Filed: April 15, 2010
    Publication date: December 27, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITY OF PITTSBURGH, INSTITUT CURIE
    Inventors: Marc Blondel, Elodie Couplan, Jean-Paul Di Rago, Daniel Dauzonne, Michael Palladino, Alicia Celotto
  • Publication number: 20120282168
    Abstract: The present application demonstrates that Salinosporamide A can be used to sensitize cancer cells to cancer therapy. Furthermore, the present application demonstrates that Salinosporamide A acts as a therapeutic agent to kill or inhibit cancer cells after sensitization of the cells by an antibody or other chemosensitizing reagents. The cancer cells can be either therapy-sensitive or therapy resistant. The present application further demonstrates that Salinosporamide A induces the expression of Raf kinase inhibitor protein (RKIP) and PTEN, tumor suppressor proteins, and inhibits the expression of YY1, a transcriptional regulator protein overexpressed in cancer cells and also inhibits the growth factor pleiotrophin (PTN).
    Type: Application
    Filed: April 26, 2012
    Publication date: November 8, 2012
    Applicants: Nereus Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: Benjamin BONAVIDA, Michael PALLADINO
  • Publication number: 20120277251
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 1, 2012
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Michael Palladino, George Kenneth Lloyd, Yoshio Hayashi
  • Publication number: 20120264678
    Abstract: Disclosed are methods of treating infectious diseases comprising administering to an animal, a therapeutically effective amount of a heterocyclic compound. The animal is a mammal, preferably a human or a rodent.
    Type: Application
    Filed: June 6, 2012
    Publication date: October 18, 2012
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventor: Michael Palladino
  • Patent number: 8247552
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: August 21, 2012
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, George Kenneth Lloyd, Yoshio Hayashi
  • Patent number: 8219778
    Abstract: The embodiments that are described herein provide random access to individual data storage locations of a group of buffers, which may be scattered in the memory. These embodiments provide a virtual memory interface that applies virtual addresses in a flat memory linear addressing space as indices into the physical memory addresses that are ordered into a sequence in accordance with the group of buffers. In this way, these embodiments enable a device (e.g., a processor) to directly and sequentially access all of the scattered physical memory locations of a fragmented data item, such as a packet, without having to perform any memory segmentation or paging processes. In some embodiments, these accesses include both read and write accesses to the scattered data storage locations.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: July 10, 2012
    Assignee: Microchip Technology Incorporated
    Inventors: Michael Palladino, Carl Gyllenhammer, Bendik Kleveland
  • Patent number: 8168803
    Abstract: Disclosed are methods of treating cancer, inflammatory conditions, and/or infectious disease in an animal comprising: administering to the animal, a therapeutically effective amount of a heterocyclic compound. The animal is a mammal, preferably a human or a rodent.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: May 1, 2012
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, Saskia Theodora Cornelia Neuteboom
  • Publication number: 20110245260
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Application
    Filed: April 4, 2011
    Publication date: October 6, 2011
    Applicant: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, George Kenneth Lloyd, Yoshio Hayashi
  • Patent number: 7919497
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: April 5, 2011
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, George Kenneth Lloyd, Yoshio Hayashi
  • Patent number: 7908455
    Abstract: A block of contiguous data storage locations of a memory is divided into pools of memory chunks. The memory chunks in same ones of the pools have equal chunk sizes. The memory chunks in different ones of the pools have different chunk sizes. In each of the pools, the memory chunks are addressable by respective chunk base physical addresses in a respective linear contiguous sequence that starts from a respective pool base physical address. The physical addresses of the memory chunks are translated into corresponding internal handles and vice versa, where each of the internal handles is smaller in size than its corresponding physical address. For each of the pools, an associated pool queue comprising respective ones of the internal handles to allocatable ones of the memory chunks in the pool is maintained.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: March 15, 2011
    Assignee: Microchip Technology Incorporated
    Inventor: Michael Palladino
  • Publication number: 20100168046
    Abstract: Disclosed are methods of treating infectious diseases comprising administering to the animal, a therapeutically effective amount of a heterocyclic compound. The animal is a mammal, preferably a human or a rodent.
    Type: Application
    Filed: March 9, 2010
    Publication date: July 1, 2010
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventor: Michael Palladino
  • Publication number: 20090285836
    Abstract: The present invention relates to methods and compositions for treating and evaluating metastatic conditions.
    Type: Application
    Filed: April 14, 2009
    Publication date: November 19, 2009
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Stavroula Baritaki, Benjamin Bonavida, Michael Palladino
  • Publication number: 20090216964
    Abstract: The embodiments that are described herein provide random access to individual data storage locations of a group of buffers, which may be scattered in the memory. These embodiments provide a virtual memory interface that applies virtual addresses in a flat memory linear addressing space as indices into the physical memory addresses that are ordered into a sequence in accordance with the group of buffers. In this way, these embodiments enable a device (e.g., a processor) to directly and sequentially access all of the scattered physical memory locations of a fragmented data item, such as a packet, without having to perform any memory segmentation or paging processes. In some embodiments, these accesses include both read and write accesses to the scattered data storage locations.
    Type: Application
    Filed: February 27, 2008
    Publication date: August 27, 2009
    Inventors: Michael Palladino, Carl Gyllenhammer, Bendik Kleveland
  • Publication number: 20090216988
    Abstract: A block of contiguous data storage locations of a memory is divided into pools of memory chunks. The memory chunks in same ones of the pools have equal chunk sizes. The memory chunks in different ones of the pools have different chunk sizes. In each of the pools, the memory chunks are addressable by respective chunk base physical addresses in a respective linear contiguous sequence that starts from a respective pool base physical address. The physical addresses of the memory chunks are translated into corresponding internal handles and vice versa, where each of the internal handles is smaller in size than its corresponding physical address. For each of the pools, an associated pool queue comprising respective ones of the internal handles to allocatable ones of the memory chunks in the pool is maintained.
    Type: Application
    Filed: February 27, 2008
    Publication date: August 27, 2009
    Inventor: Michael Palladino
  • Patent number: 7579371
    Abstract: Disclosed are methods of treating cancer comprising administering to the animal, a therapeutically effective amount of a heterocyclic compound of Formula VI. The animal is a mammal, preferably a human or a rodent.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: August 25, 2009
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Michael Palladino, Barbara Christine Potts, Venkata Rami Reddy Macherla, Saskia Theodora Cornelia Neuteboom
  • Publication number: 20090207824
    Abstract: A wireless (such as Wi-Fi or similar) access point is included in or attached to a device, such as a cellular phone, WiMAX device, other mobile device, etc. One or more wireless units wirelessly access a communication network (and in some cases the Internet) through the wireless access point device. Additionally, such a wireless access point device can receive a transmission from a wireless tag that has been attached to an object to be monitored and can forward information from the wireless tag to a target device along with location information.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 20, 2009
    Applicant: ZeroG Wireless, Inc.
    Inventors: Thomas H. Lee, Michael Palladino, Bendik Kleveland, Vinay Malekal
  • Patent number: 7572606
    Abstract: Disclosed are methods of modulating biosynthesis of Salinosporamide A and its analogs, which are useful in treating cancer, inflammatory conditions, and/or infectious disease. The methods involve, for example, genetic manipulation, selection of reagents in the fermentation feedstock, and selection of fermentation conditions.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: August 11, 2009
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Kin Sing Lam, Michael Palladino, Ginger Tsueng